









Markets
/
Stocks
/
nasdaq-med
/

Medifast Inc

MED

14.350USD

-0.210-1.44%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

157.72MMarket Cap

43.35P/E TTM



Medifast Inc

14.350

-0.210-1.44%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

43 / 102

Overall Ranking

193 / 4720

Industry

Food & Tobacco

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Hold

Current Rating

15.000

Target Price

+2.95%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.

Overvalued

The company’s latest PE is 43.21, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 8.65M shares, decreasing 34.87% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 813.31K shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.67, which is lower than the Food & Tobacco industry's average of 7.03. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 105.56M, representing a year-over-year decrease of 37.38%, while its net profit experienced a year-over-year decrease of 130.41%.

Score

Industry at a Glance

Previous score

6.67

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

5.17

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.05

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.89

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

5.27

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 8.91, which is higher than the Food & Tobacco industry's average of 5.38. Its current P/E ratio is 43.87, which is -79.71% below the recent high of 8.90 and 85.65% above the recent low of 6.29.

Score

Industry at a Glance

Previous score

8.91

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 43/102

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 6.00, which is lower than the Food & Tobacco industry's average of 7.40. The average price target for Medifast Inc is 15.00, with a high of 15.00 and a low of 15.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Hold

Current Rating

15.000

Target Price

+4.53%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Medifast Inc

MED

Mondelez International Inc

MDLZ

Hershey Co

HSY

Kraft Heinz Co

KHC

General Mills Inc

GIS

Campbell's Co

CPB

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 4.88, which is lower than the Food & Tobacco industry's average of 6.67. Sideways: Currently, the stock price is trading between the resistance level at 15.04 and the support level at 13.74, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

4.88

Change

-0.14

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.115

Buy

RSI(14)

56.470

Neutral

STOCH(KDJ)(9,3,3)

76.775

Neutral

ATR(14)

0.411

High Vlolatility

CCI(14)

123.555

Buy

Williams %R

24.615

Buy

TRIX(12,20)

0.140

Sell

StochRSI(14)

33.480

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

14.326

Buy

MA10

14.095

Buy

MA20

14.045

Buy

MA50

13.866

Buy

MA100

13.712

Buy

MA200

14.539

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 7.00, which is higher than the Food & Tobacco industry's average of 6.83. The latest institutional shareholding proportion is 78.71%, representing a quarter-over-quarter decrease of 2.15%. The largest institutional shareholder is James Simons, holding a total of 813.31K shares, representing 7.40% of shares outstanding, with 10.44% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Renaissance Technologies LLC

Star Investors

888.93K

BlackRock Institutional Trust Company, N.A.

855.39K

+1.63%

The Vanguard Group, Inc.

Star Investors

763.56K

+2.13%

Charles Schwab Investment Management, Inc.

265.57K

+132.68%

Two Sigma Investments, LP

435.72K

-2.76%

Acadian Asset Management LLC

385.72K

+41.49%

BofA Global Research (US)

288.51K

+4.51%

Parametric Portfolio Associates LLC

214.74K

+88.69%

D. E. Shaw & Co., L.P.

333.45K

+15.47%

Geode Capital Management, L.L.C.

256.48K

+4.29%

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.68, which is lower than the Food & Tobacco industry's average of 4.35. The company's beta value is 0.88. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.